TLR9 and B-cell chronic lymphocytic leukemia: Activation and proliferation following stimulation with TLR9 ligand differs between B-CLL cells and normal B-cells in terms of IL-6 production, CD40 expression, and regulation of early cell cycle progression (e.g., regulation of cyclin D3 and p27 expression) (257, 258).